Elminda

elminda is an inspiring brain-tech company addressing one of the ultimate challenges - understanding the human brain to pave a path for better brain health. The Company is addressing this goal with the PREDICT tool for advanced personalised medicine. The company is widely recognized for its innovative approach to neuroscience, ranking among Fast Company’s annual list of the World's most innovative companies and a World Economic
Forum Technology Pioneer. Its first product the Brain Network Analytics (BNA) technology has been adopted in 40+ clinical settings worldwide.  

Established in 2006 in Israel with marketing and sales branches in the US and Germany, elminda has 45 employees with offices in Herzeliya (Israel) and Chicago (US). The Company, managed by business professionals with proven track record in the medical device and diagnostics space, is a unique blend of highly experienced international neuroscientists, physicians, computer and data scientists, and algorithm and software engineers.
Together, they contribute to develop the three key core competencies of the company: Artificial intelligence, Big data, and Advanced algorithms. These core competencies set the basis of elminda unique products. Currently the company holds more than 60 patents and a proprietary large database. The Company boasts a wide network of partnerships across the world with leaders in the academic, clinical, industrial and pharmaceutical sectors.